DRD2 and schizophrenia: Striatal dopamine D2 receptor overexpression produces motivational and cognitive impairment associated with schizophrenia (Kellendonk et al. 2006; Simpson et al. 2011) and alterations in the PFC inhibitory transmission (Li et al. 2011) reminiscent to those observed after the PCP treatment.